Specific binding of anti-N-acetyllactosamine monoclonal antibody 1B2 to acute myeloid leukaemia cells
- 31 January 1992
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 28 (1) , 37-41
- https://doi.org/10.1016/0959-8049(92)90380-k
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Surface marker expression in adult acute myeloid leukaemia: correlations with initial characteristics, morphology and response to therapyBritish Journal of Haematology, 1989
- Treatment of acute myeloid leukemia cells in vitro with a monoclonal antibody recognizing a myeloid differentiation antigen allows normal progenitor cells to be expressed.Journal of Clinical Investigation, 1987
- The use of monoclonal antibodies for the identification and classification of acute myeloid leukemiasLeukemia Research, 1986
- Proposed Revised Criteria for the Classification of Acute Myeloid LeukemiaAnnals of Internal Medicine, 1985
- Anti-My-28, an antigranulocyte mouse monoclonal antibody, binds to a sugar sequence in lacto-N-neotetraoseBlood, 1985
- Heterogeneity of clonogenic cells in acute myeloblastic leukemia.Journal of Clinical Investigation, 1985
- Surface phenotype of clonogenic cells in acute myeloid leukemia defined by monoclonal antibodiesBlood, 1984
- Expression of myeloid differentiation antigens on normal and malignant myeloid cells.Journal of Clinical Investigation, 1981
- Studies of human pluripotential hemopoietic stem cells (CFU-GEMM) in vitroBlood, 1981